SAT and VAT are functionally heterogeneous and contribute differently to metabolic diseases depending on their differential capacities of lipolysis, lipogenesis, insulin sensitivity, and secretion of inflammatory cytokines (Lafontan & Berlan, 2003). This evidence concerns the gene INS and metabolic disease.